Home / Healthcare / Pharmaceutical / U.S. Diabetes Drugs Market
U.S. Diabetes Drugs Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Insulin, DPP-4 Inhibitors, GLP-1 Receptor Agonists, SGLT2 Inhibitors, and Others), By Diabetes Type (Type 1 and Type 2), By Route of Administration (Oral, Subcutaneous, and Intravenous), By Distribution Channel (Online Pharmacies, Hospital Pharmacies, and Retail Pharmacies), and Country Forecast, 2023-2030
Report Format: PDF | Latest Update: Aug, 2024 | Published Date: Feb, 2024 | Report ID: FBI109115 | Status : PublishedSummary
TOC
Methodology
Market Segmentation
Infographics
- 2022
- 80